Representative Marjorie Taylor Greene (R-Georgia) recently bought shares of Morgan Stanley NYSE: MS. In a filing disclosed on May 19th, the Representative disclosed that they had bought between $1,001 and $15,000 in Morgan Stanley stock on May 14th.
Representative Marjorie Taylor Greene also recently made the following trade(s):
- Purchased $1,001 - $15,000 in shares of UnitedHealth Group NYSE: UNH on 5/16/2025.
- Purchased $1,001 - $15,000 in shares of Eli Lilly and Company NYSE: LLY on 5/14/2025.
- Purchased $1,001 - $15,000 in shares of Impinj NASDAQ: PI on 5/14/2025.
- Purchased $1,001 - $15,000 in shares of Corning NYSE: GLW on 5/14/2025.
- Purchased $1,001 - $15,000 in shares of Cardinal Health NYSE: CAH on 5/14/2025.
- Purchased $1,001 - $15,000 in shares of Chevron NYSE: CVX on 5/14/2025.
- Purchased $15,001 - $50,000 in shares of UnitedHealth Group NYSE: UNH on 5/14/2025.
- Purchased $1,001 - $15,000 in shares of Blackstone NYSE: BX on 5/14/2025.
- Purchased $1,001 - $15,000 in shares of ServiceNow NYSE: NOW on 5/14/2025.
- Purchased $1,001 - $15,000 in shares of Hershey NYSE: HSY on 5/14/2025.
Morgan Stanley Trading Down 0.1%
Shares of NYSE MS traded down $0.12 during midday trading on Monday, hitting $126.14. The stock had a trading volume of 3,360,802 shares, compared to its average volume of 6,712,607. The firm has a market cap of $202.38 billion, a P/E ratio of 15.89, a price-to-earnings-growth ratio of 1.18 and a beta of 1.30. Morgan Stanley has a fifty-two week low of $90.94 and a fifty-two week high of $142.03. The company has a debt-to-equity ratio of 3.14, a current ratio of 0.80 and a quick ratio of 0.80. The company's 50-day simple moving average is $117.04 and its 200 day simple moving average is $125.44.
Morgan Stanley (NYSE:MS - Get Free Report) last posted its quarterly earnings results on Friday, April 11th. The financial services provider reported $2.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.21 by $0.39. The business had revenue of $17.74 billion for the quarter, compared to analysts' expectations of $16.81 billion. Morgan Stanley had a return on equity of 14.39% and a net margin of 12.48%. The firm's quarterly revenue was up 17.2% compared to the same quarter last year. During the same quarter last year, the business earned $2.02 earnings per share. Research analysts anticipate that Morgan Stanley will post 8.56 EPS for the current year.
Morgan Stanley Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Thursday, May 15th. Shareholders of record on Wednesday, April 30th were given a $0.925 dividend. The ex-dividend date was Wednesday, April 30th. This represents a $3.70 dividend on an annualized basis and a yield of 2.93%. Morgan Stanley's payout ratio is 43.43%.
Wall Street Analysts Forecast Growth
Several brokerages have recently commented on MS. Erste Group Bank cut shares of Morgan Stanley from a "strong-buy" rating to a "hold" rating in a research report on Monday, March 17th. Bank of America reduced their price objective on shares of Morgan Stanley from $150.00 to $144.00 and set a "buy" rating on the stock in a research note on Wednesday, April 2nd. Evercore ISI dropped their target price on shares of Morgan Stanley from $150.00 to $138.00 and set an "outperform" rating for the company in a research report on Tuesday, April 1st. JMP Securities reissued a "market perform" rating on shares of Morgan Stanley in a research note on Monday, April 14th. Finally, Wells Fargo & Company decreased their price objective on Morgan Stanley from $130.00 to $120.00 and set an "equal weight" rating for the company in a research note on Monday, April 14th. Twelve research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $132.46.
Read Our Latest Stock Analysis on Morgan Stanley
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Lindbrook Capital LLC lifted its holdings in shares of Morgan Stanley by 1.2% during the 4th quarter. Lindbrook Capital LLC now owns 6,156 shares of the financial services provider's stock valued at $774,000 after purchasing an additional 73 shares in the last quarter. 1ST Source Bank lifted its stake in Morgan Stanley by 0.5% in the fourth quarter. 1ST Source Bank now owns 15,925 shares of the financial services provider's stock valued at $2,002,000 after buying an additional 73 shares in the last quarter. Moors & Cabot Inc. lifted its stake in Morgan Stanley by 1.6% in the fourth quarter. Moors & Cabot Inc. now owns 4,727 shares of the financial services provider's stock valued at $594,000 after buying an additional 76 shares in the last quarter. DGS Capital Management LLC boosted its holdings in shares of Morgan Stanley by 1.8% in the fourth quarter. DGS Capital Management LLC now owns 4,408 shares of the financial services provider's stock valued at $554,000 after buying an additional 77 shares during the period. Finally, Omnia Family Wealth LLC increased its position in shares of Morgan Stanley by 2.5% during the fourth quarter. Omnia Family Wealth LLC now owns 3,140 shares of the financial services provider's stock worth $395,000 after acquiring an additional 77 shares in the last quarter. 84.19% of the stock is currently owned by institutional investors.
Insider Buying and Selling
In other Morgan Stanley news, Director Robert H. Herz sold 800 shares of the business's stock in a transaction that occurred on Friday, May 2nd. The stock was sold at an average price of $119.32, for a total value of $95,456.00. Following the sale, the director now owns 96,760 shares in the company, valued at approximately $11,545,403.20. The trade was a 0.82% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Andrew M. Saperstein sold 40,000 shares of the company's stock in a transaction that occurred on Friday, May 2nd. The stock was sold at an average price of $120.00, for a total value of $4,800,000.00. Following the transaction, the insider now directly owns 335,765 shares of the company's stock, valued at approximately $40,291,800. This trade represents a 10.64% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 50,868 shares of company stock worth $6,019,548 over the last ninety days. Company insiders own 0.19% of the company's stock.
About Representative Greene
Marjorie Taylor Greene (Republican Party) is a member of the U.S. House, representing Georgia's 14th Congressional District. She assumed office on January 3, 2021. Her current term ends on January 3, 2027.
Greene (Republican Party) is running for re-election to the U.S. House to represent Georgia's 14th Congressional District. She declared candidacy for the 2026 election.
Morgan Stanley Company Profile
(
Get Free Report)
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.
Recommended Stories
Before you consider Morgan Stanley, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Morgan Stanley wasn't on the list.
While Morgan Stanley currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report